EUVIMEDEUVIMED entdecken
Crossref

Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss

Haibo Liang, Qihang Wu, Tianyong Hua, Yiqi Chen, Jiangtao Luo, Jiansen Miao, Hong Su, Shu Yang, Jiake Xu, Xiangyang Wang, Haiming Jin

International Immunopharmacology · 2025-12 · 166 · 115589

DOI: 10.1016/j.intimp.2025.115589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Haibo Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Spine Surgery, Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, W…. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Osteoclasts, Osteoporosis, Bone Resorption. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Basic Research Project of Wenzhou City, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kelch-Like ECH-Associated Protein 1OsteoclastsOsteoporosisBone ResorptionChalconesAnimalsNF-E2-Related Factor 2OvariectomyFemaleOsteogenesisMiceSignal TransductionHumansReactive Oxygen SpeciesMice, Inbred C57BLRAW 264.7 Cells

Stichwörter der Autor:innen

OsteoclastogenesisOsteoporosisSofalcone

Substanzen

Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Keap1 protein, mouseReactive Oxygen SpeciesNfe2l2 protein, mouseChalcones

Autor:innen und Institutionen

  • Division of Spine Surgery, Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; School of the Second Clinical Medical Sciences, Wenzhou…
  • School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China. Electronic address: jiake.xu@siat.ac.c…

Förderung

  • Basic Research Project of Wenzhou City
  • National Natural Science Foundation of China

Zitieren

APA

Liang, H., Wu, Q., Hua, T., Chen, Y., Luo, J., Miao, J., Su, H., Yang, S., Xu, J., Wang, X., & Jin, H. (2025). Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss. International Immunopharmacology, 166, 115589. https://doi.org/10.1016/j.intimp.2025.115589

Vancouver

Liang H, Wu Q, Hua T, Chen Y, Luo J, Miao J, et al. Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss. International Immunopharmacology. 2025;166:115589. doi:10.1016/j.intimp.2025.115589

BibTeX
@article{Liang2025,
  author = {Liang, Haibo and Wu, Qihang and Hua, Tianyong and Chen, Yiqi and Luo, Jiangtao and Miao, Jiansen and Su, Hong and Yang, Shu and Xu, Jiake and Wang, Xiangyang and Jin, Haiming},
  title = {Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {166},
  pages = {115589},
  doi = {10.1016/j.intimp.2025.115589}
}
Kostenlos starten →